英語論文を38本追加しました
- サイト管理者
- 1月2日
- 読了時間: 3分
2025年10月3日検索分、10月10日検索分、10月17日検索分、10月24日検索分、10月31日検索分の合計38本を追加しました。
日本の先生方の論文は5本です。
AZP2006 in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open-Label Extension on Safety, Biomarkers, and Disease Progression |
Visual interpretation of [(18)F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy |
A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions |
Understanding Tau pathology: Insights from animal models |
Tracking prodromal Parkinson's disease: a five-year follow-up of the PARCAS cohort |
Imaging of Proteinopathies in the Brains of Parkinsonian Disorders パーキンソン症候群患者の脳におけるタンパク質異常の画像化 |
A novel lncRNA FAM151B-DT regulates degradation of aggregation prone proteins |
No anti-IgLON5 antibody in carefully diagnosed PSP patients with "atypical" or variant clinical features |
Polyneuropathy in Parkinson's disease and atypical Parkinsonian syndromes: clinical impact and risk factors |
A Case of Progressive Supranuclear Palsy with Predominant Speech/Language Disorder 言語障害が優位な進行性核上性麻痺の症例 |
Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathology |
Unraveling the mystery of alien hand syndrome: when your hand has a mind of its own |
Cross-sectional and longitudinal validation of short and long versions of the progressive supranuclear palsy quality of life scale |
A Biomarker-Based Classification of Corticobasal Syndrome |
Patterns and causes of supranuclear vertical gaze palsy: A retrospective, single-institutional study in 113 patients |
[Classification and Clinical Characteristics of Dementia] 認知症の分類 |
Brain linear measurement index in the differential diagnosis between idiopathic normal pressure hydrocephalus and progressive supranuclear palsy |
A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network |
Protein fingerprints of brain-derived extracellular vesicles predict types of tau pathology |
Immune system modifications in atypical parkinsonism related to autoimmunity - a case control study |
Expanding the genetic spectrum of corticobasal syndrome: novel CCNF p.M394L variant from a South Asian cohort |
Investigating the impact of white matter hyperintensities on longitudinal progression in progressive supranuclear palsy |
The Effects of Multimodal Exercise on Sleep Quality and Architecture, Motor Function, Cognition, Fatigue, and Systemic Inflammation in Corticobasal Syndrome: A Case Report |
Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markers |
Absence of STN Neuronal Activity during MER in DBS Surgery: Diagnostic and Clinical Implications DBS手術におけるMER中のSTN神経活動の欠如:診断的および臨床的意義 |
LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopathies and synucleinopathies |
Comparing and combining TSPO-PET tracers in tauopathies |
Early subtypes and progressions of progressive supranuclear palsy: a data-driven brain bank study 進行性核上性麻痺の早期サブタイプと進行:データ駆動型脳バンク研究 |
Discordant cerebrospinal fluid and positron emission tomography amyloid biomarkers in an APP mutation carrier presenting corticobasal syndrome |
FibrilPaint to determine the length of Tau amyloids in fluids |
Deceleration Capacity as a Marker of Autonomic Cardiac Modulation in Prodromal and Manifest Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy |
Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural Basis |
Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases |
Neuronal-specific antibody in patients with multiple system atrophy and progressive supranuclear palsy |
A Mathematical Model of Cellular Aggregation Predicts Patterns of Tau Accumulation in Neurodegenerative Disease |
Reviewer Comment on Kazemi et al. "Assessment of Clinical and Demographic Factors Influencing the Severity of Levodopa-Induced Dyskinesia" |
Toward Biology-Driven Diagnosis of Atypical Parkinsonian Disorders |
The Neuro-Ophthalmologic Manifestations of SPG7-Associated Disease |

コメント